Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 8
1947 6
1948 17
1949 9
1950 16
1951 21
1952 20
1953 19
1954 16
1955 12
1956 6
1957 17
1958 15
1959 17
1960 14
1961 23
1962 32
1963 33
1964 47
1965 59
1966 60
1967 65
1968 51
1969 84
1970 59
1971 59
1972 71
1973 66
1974 70
1975 73
1976 78
1977 83
1978 97
1979 100
1980 99
1981 110
1982 131
1983 127
1984 126
1985 129
1986 121
1987 128
1988 134
1989 158
1990 145
1991 150
1992 145
1993 146
1994 175
1995 149
1996 161
1997 170
1998 177
1999 181
2000 214
2001 175
2002 183
2003 201
2004 187
2005 205
2006 247
2007 220
2008 237
2009 237
2010 232
2011 255
2012 271
2013 293
2014 308
2015 328
2016 355
2017 392
2018 430
2019 445
2020 526
2021 615
2022 586
2023 601
2024 222

Text availability

Article attribute

Article type

Publication date

Search Results

2,476 results

Results by year

Filters applied: in the last 5 years. Clear all
Page 1
Giant Cell Arteritis and Polymyalgia Rheumatica: Treatment Approaches and New Targets.
Nepal D, Putman M, Unizony S. Nepal D, et al. Rheum Dis Clin North Am. 2023 Aug;49(3):505-521. doi: 10.1016/j.rdc.2023.03.005. Epub 2023 Apr 18. Rheum Dis Clin North Am. 2023. PMID: 37331730 Review.
Prolonged glucocorticoid tapers have been the standard of care for giant cell arteritis (GCA) and polymyalgia rheumatica (PMR), but recent advancements have improved outcomes for patients with GCA while reducing glucocorticoid-related toxicities …
Prolonged glucocorticoid tapers have been the standard of care for giant cell arteritis (GCA) and polymyalgia …
Treat-to-target recommendations in giant cell arteritis and polymyalgia rheumatica.
Dejaco C, Kerschbaumer A, Aletaha D, Bond M, Hysa E, Camellino D, Ehlers L, Abril A, Appenzeller S, Cid MC, Dasgupta B, Duftner C, Grayson PC, Hellmich B, Hočevar A, Kermani TA, Matteson EL, Mollan SP, Neill L, Ponte C, Salvarani C, Sattui SE, Schmidt WA, Seo P, Smolen JS, Thiel J, Toro-Gutiérrez CE, Whitlock M, Buttgereit F. Dejaco C, et al. Ann Rheum Dis. 2024 Jan 2;83(1):48-57. doi: 10.1136/ard-2022-223429. Ann Rheum Dis. 2024. PMID: 36828585 Free PMC article.
OBJECTIVES: To develop treat-to-target (T2T) recommendations in giant cell arteritis (GCA) and polymyalgia rheumatica (PMR). METHODS: A systematic literature review was conducted to retrieve data on treatment targets and outcomes in GCA/PMR as w …
OBJECTIVES: To develop treat-to-target (T2T) recommendations in giant cell arteritis (GCA) and polymyalgia rh …
Giant-Cell Arteritis.
Rebello A, Joshi P. Rebello A, et al. N Engl J Med. 2022 Oct 13;387(15):e36. doi: 10.1056/NEJMicm2202567. Epub 2022 Oct 8. N Engl J Med. 2022. PMID: 36214594 No abstract available.
Giant cell arteritis or polymyalgia rheumatica after influenza vaccination: A study of 12 patients and a literature review.
Liozon E, Parreau S, Filloux M, Dumonteil S, Gondran G, Bezanahary H, Ly KH, Fauchais AL. Liozon E, et al. Autoimmun Rev. 2021 Feb;20(2):102732. doi: 10.1016/j.autrev.2020.102732. Epub 2020 Dec 14. Autoimmun Rev. 2021. PMID: 33326851 Review.
INTRODUCTION: Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are inflammatory rheumatic diseases common in people over the age of 50 years. ...
INTRODUCTION: Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are inflammatory rheumatic dise …
An update on polymyalgia rheumatica.
Lundberg IE, Sharma A, Turesson C, Mohammad AJ. Lundberg IE, et al. J Intern Med. 2022 Nov;292(5):717-732. doi: 10.1111/joim.13525. Epub 2022 Jun 11. J Intern Med. 2022. PMID: 35612524 Free PMC article. Review.
Polymyalgia rheumatica (PMR) is the most common inflammatory rheumatic disease affecting people older than 50 years and is 2-3 times more common in women. ...This is associated with high rates of GC-related comorbidities, such as diabetes and osteoporosis, and there …
Polymyalgia rheumatica (PMR) is the most common inflammatory rheumatic disease affecting people older than 50 years and is 2-3 …
Subclinical giant cell arteritis in polymyalgia rheumatica: Concurrent conditions or a common spectrum of inflammatory diseases?
Salvarani C, Padoan R, Iorio L, Tomelleri A, Terrier B, Muratore F, Dasgupta B. Salvarani C, et al. Autoimmun Rev. 2024 Jan;23(1):103415. doi: 10.1016/j.autrev.2023.103415. Epub 2023 Aug 23. Autoimmun Rev. 2024. PMID: 37625672 Free article. Review.
Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are common conditions in older adults. ...
Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are common conditions in older adults. ...
Polymyalgia Rheumatica and Giant Cell Arteritis: Rapid Evidence Review.
Raleigh MF, Stoddard J, Darrow HJ. Raleigh MF, et al. Am Fam Physician. 2022 Oct;106(4):420-426. Am Fam Physician. 2022. PMID: 36260899
Polymyalgia rheumatica and giant cell arteritis are inflammatory conditions that occur predominantly in people 50 years and older, with peak incidence at 70 to 75 years of age. ...Methotrexate may be considered as an adjunct to glucocorticoids i …
Polymyalgia rheumatica and giant cell arteritis are inflammatory conditions that occur predominantly in p …
Pathogenesis, Diagnosis and Management of Polymyalgia Rheumatica.
Camellino D, Giusti A, Girasole G, Bianchi G, Dejaco C. Camellino D, et al. Drugs Aging. 2019 Nov;36(11):1015-1026. doi: 10.1007/s40266-019-00705-5. Drugs Aging. 2019. PMID: 31493201 Review.
Polymyalgia rheumatica can occur independently or in association with giant cell arteritis, which is the most common form of primary vasculitis. The diagnosis of polymyalgia rheumatica is usually based on clinical presentation and …
Polymyalgia rheumatica can occur independently or in association with giant cell arteritis, which is the …
Polymyalgia Rheumatica and Giant Cell Arteritis.
Buttgereit F, Matteson EL, Dejaco C. Buttgereit F, et al. JAMA. 2020 Sep 8;324(10):993-994. doi: 10.1001/jama.2020.10155. JAMA. 2020. PMID: 32897333 Review. No abstract available.
Predictive Factors of Giant Cell Arteritis in Polymyalgia Rheumatica Patients.
Ramon A, Greigert H, Ornetti P, Maillefert JF, Bonnotte B, Samson M. Ramon A, et al. J Clin Med. 2022 Dec 14;11(24):7412. doi: 10.3390/jcm11247412. J Clin Med. 2022. PMID: 36556036 Free PMC article. Review.
Polymyalgia rheumatica (PMR) is an inflammatory rheumatism of the shoulder and pelvic girdles. In 16 to 21% of cases, PMR is associated with giant cell arteritis (GCA) that can lead to severe vascular complications. ...
Polymyalgia rheumatica (PMR) is an inflammatory rheumatism of the shoulder and pelvic girdles. In 16 to 21% of cases, PMR is a …
2,476 results